Clinical Trials Logo

Clinical Trial Summary

The researchers are trying to compare the effectiveness of Vertebral Fracture Assessment (VFA) in addition to the current standard of care spine x-ray in evaluation pre-liver transplant patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03811873
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date February 18, 2019
Completion date August 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT04985409 - Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant N/A
Recruiting NCT05441436 - Neuropsychological and Biopsychosocial Evolution During Pediatric Transplantation: Pre/Post-stages and at 6 Months
Recruiting NCT05798286 - Quantra® System With the QPlus® Cartridge in Double-lung Transplantation N/A
Terminated NCT02434146 - Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy Phase 1/Phase 2
Withdrawn NCT03399227 - Liver Transplantation: Skeletal Effects
Recruiting NCT05967130 - Treatment Chronic UTI Post Kidney Transplant Phase 3
Recruiting NCT05600855 - Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model Phase 2
Recruiting NCT05599256 - Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model Phase 2
Completed NCT05629923 - EVALUATION OF DIFFERENT PROPHYLACTIC INTERVENTIONS TOWARD COVID-19 IN SOLID ORGAN TRANSPLANT PATIENTS
Completed NCT03448679 - Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT N/A
Active, not recruiting NCT03769441 - Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation Phase 3
Active, not recruiting NCT03636412 - Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients N/A
Recruiting NCT06066957 - Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients Phase 2
Recruiting NCT03015012 - Nutrigenomics, Overweight/Obesity and Weight Management Trial (NOW Trial) N/A
Not yet recruiting NCT06208137 - Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution. N/A
Not yet recruiting NCT04756622 - N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. Phase 3
Available NCT06393660 - Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)